Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes
Shayan Sharif(Diabetes Canada), Guillermo Arreaza(Diabetes Canada), Peter Zucker(Diabetes Canada), Qing‐Sheng Mi(Diabetes Canada), Jitin Sondhi(Diabetes Canada), Olga V. Naidenko(La Jolla Institute for Immunology), Mitchell Kronenberg(La Jolla Institute for Immunology), Yasuhiko Koezuka(Kirin (Japan)), Terry L. Delovitch(Western University), Jean‐Marc Gombert(Université Claude Bernard Lyon 1), Maria Leite‐de‐Moraes(Hôpital Necker-Enfants Malades), Christine Gouarin(Université Claude Bernard Lyon 1), Ren Zhu(Université Claude Bernard Lyon 1), Agathe Hameg(Université Claude Bernard Lyon 1), Toshinori Nakayama(Chiba University), Masaru Taniguchi(Chiba University), Françoise Lepault(Hôpital Necker-Enfants Malades), Agnès Lehuen(Université Claude Bernard Lyon 1), Jean‐François Bach(Université Claude Bernard Lyon 1), André Herbelin(Université Claude Bernard Lyon 1)
Cited by 599
Abstract
Related Papers
No related papers found
Powered by citation graph analysis